TY - JOUR
T1 - Impact of renal function in patients with multi-vessel coronary disease on long-term mortality following coronary artery bypass grafting compared with percutaneous coronary intervention
AU - Sugumar, Hariharan
AU - Lancefield, Terase
AU - Andrianopoulos, Nick
AU - Duffy, Stephen
AU - Ajani, Andrew Edward
AU - Freeman, Melanie
AU - Buxton, Brian F
AU - Brennan, Angela Leone
AU - Yan, Bryan P
AU - Dinh, Diem Thi Thuy
AU - Smith, Julian Anderson
AU - Charter, Kerrie
AU - Farouque, Omar
AU - Reid, Christopher Michael
AU - Clarke, David John
PY - 2014
Y1 - 2014
N2 - Background Comorbidities, such as diabetes, affect revascularization strategy for coronary disease. We sought to determine if the degree of renal impairment affected long-term mortality after percutaneous coronary intervention (PCI) compared to coronary artery bypass grafting (CABG) in patients with multi-vessel coronary disease (MVD). Methods and results 8970 patients with MVD undergoing revascularization between 2004 and 2008, in two multi-center parallel PCI and CABG Australian registries were assigned to three groups based on their estimated glomerular filtration rate (eGFR) = 60 mL/min/1.73 m2 (n = 1678:839), 30-59 mL/min/1.73 m2 (n = 452:226) and <30 mL/min/1.73 m2 (n = 74:37). We used 2:1 propensity matching to compare 3306 patients undergoing primary CABG versus PCI. Shock, myocardial infarction (MI) <24 h, previous CABG, valve surgery or PCI were exclusions. Long-term mortality (mean 3.1 years) was compared with Cox-proportional hazard-adjusted modeling. Observed long-term mortality rates (CABG vs. PCI) were 4.5 vs. 4.3 p = 0.84, 12.8 vs. 17.3 p = 0.12, and 23.0 vs. 40.5 p = 0.05 in the three strata, respectively. In patients with eGFR = 60 mL/min/1.73 m2, long-term mortality between PCI and CABG (HR 0.99, 95 CI 0.65-1.49, p = 0.95) was similar. However, amongst patients with eGFR 30-59 mL/min/1.73 m2, there was a significant mortality hazard with PCI (HR 2.00, 95 CI 1.32-3.04, p = 0.001). In patients with eGFR <30 mL/min/1.73 m2, there was a trend for hazard with PCI (HR 1.66, 95 CI 0.80-3.46, p = 0.17). Conclusion Long-term mortality in MVD patients with preserved renal function was very low and similar between PCI and CABG. However there was a long-term mortality hazard associated with PCI amongst patients with moderate renal impairment.
AB - Background Comorbidities, such as diabetes, affect revascularization strategy for coronary disease. We sought to determine if the degree of renal impairment affected long-term mortality after percutaneous coronary intervention (PCI) compared to coronary artery bypass grafting (CABG) in patients with multi-vessel coronary disease (MVD). Methods and results 8970 patients with MVD undergoing revascularization between 2004 and 2008, in two multi-center parallel PCI and CABG Australian registries were assigned to three groups based on their estimated glomerular filtration rate (eGFR) = 60 mL/min/1.73 m2 (n = 1678:839), 30-59 mL/min/1.73 m2 (n = 452:226) and <30 mL/min/1.73 m2 (n = 74:37). We used 2:1 propensity matching to compare 3306 patients undergoing primary CABG versus PCI. Shock, myocardial infarction (MI) <24 h, previous CABG, valve surgery or PCI were exclusions. Long-term mortality (mean 3.1 years) was compared with Cox-proportional hazard-adjusted modeling. Observed long-term mortality rates (CABG vs. PCI) were 4.5 vs. 4.3 p = 0.84, 12.8 vs. 17.3 p = 0.12, and 23.0 vs. 40.5 p = 0.05 in the three strata, respectively. In patients with eGFR = 60 mL/min/1.73 m2, long-term mortality between PCI and CABG (HR 0.99, 95 CI 0.65-1.49, p = 0.95) was similar. However, amongst patients with eGFR 30-59 mL/min/1.73 m2, there was a significant mortality hazard with PCI (HR 2.00, 95 CI 1.32-3.04, p = 0.001). In patients with eGFR <30 mL/min/1.73 m2, there was a trend for hazard with PCI (HR 1.66, 95 CI 0.80-3.46, p = 0.17). Conclusion Long-term mortality in MVD patients with preserved renal function was very low and similar between PCI and CABG. However there was a long-term mortality hazard associated with PCI amongst patients with moderate renal impairment.
UR - http://www.sciencedirect.com/science/article/pii/S0167527314003076
U2 - 10.1016/j.ijcard.2014.01.096
DO - 10.1016/j.ijcard.2014.01.096
M3 - Article
SN - 0167-5273
VL - 172
SP - 442
EP - 449
JO - International Journal of Cardiology
JF - International Journal of Cardiology
IS - 2
ER -